Morgan Noble Healthcare Partners

Mindoula Health, Inc. is a mental health care and behavioral health management company based in Silver Spring, Maryland. Established in 2013, it offers a technology-enabled platform that identifies, engages, and supports patients facing complex behavioral, medical, and social challenges throughout the entire continuum of care. The company provides both multiplatform and in-person behavioral health care management services to hospitals, treatment centers, primary care physician practices, and directly to patients and their families. Mindoula operates in multiple states, including Maryland, Virginia, the District of Columbia, Nevada, Louisiana, New Jersey, Michigan, Florida, Texas, Georgia, Pennsylvania, Mississippi, and California.

Finch Therapeutics is a mission-driven microbiome engineering company, is developing novel microbial therapies to serve patients with serious and unmet medical needs. The company uses machine learning algorithms to reverse engineer successful fecal transplantations and other clinical datasets, identifying the microbes that drive responses in patients. This human-centric discovery model leverages clinical data to focus on in-vitro and in-vivo efforts on cocktails of microbes that have already demonstrated safety and efficacy in humans. This enables early retirement of translational risk and avoids the challenges of extrapolating host-specific effects from animal models. Finch Therapeutics was founded in 2017 and is headquartered in Somerville, Massachusetts.

Filtricine, Inc. is a clinical-stage biotechnology company based in Santa Clara, California, focused on developing therapeutic products for cancer treatment. Founded in 2017, the company specializes in a novel nutrient modulation platform that targets and depletes essential nutrients critical for cancer cell growth. By exploiting the metabolic vulnerabilities of cancer cells, Filtricine aims to halt the spread of cancer without relying on traditional drug substances. This approach allows healthcare professionals to utilize targeted nutrient deprivation therapy to address a broad spectrum of cancers effectively.

Finch Therapeutics is a mission-driven microbiome engineering company, is developing novel microbial therapies to serve patients with serious and unmet medical needs. The company uses machine learning algorithms to reverse engineer successful fecal transplantations and other clinical datasets, identifying the microbes that drive responses in patients. This human-centric discovery model leverages clinical data to focus on in-vitro and in-vivo efforts on cocktails of microbes that have already demonstrated safety and efficacy in humans. This enables early retirement of translational risk and avoids the challenges of extrapolating host-specific effects from animal models. Finch Therapeutics was founded in 2017 and is headquartered in Somerville, Massachusetts.

TARA Biosystems, Inc. is a biotechnology company focused on developing organ-on-a-chip technology, specifically human cardiac tissue models, to enhance drug discovery and safety assessments. Founded in 2014 and based in the United States, the company utilizes stem cell-derived cardiac tissue that mimics adult physiological conditions, enabling precise measurement of cardiac functionality. This innovative platform aims to facilitate the faster and safer development of new therapies by providing predictive in vitro models that can assess the effects of drug compounds on heart function without the need for human testing. Through its advanced technology, TARA Biosystems seeks to improve the health of patients by enabling more reliable assessments of cardiac drug efficacy and safety.

SyntheX, Inc. is a biotechnology company that focuses on drug discovery through a unique screening platform designed to identify and design therapeutics for oncology and other biotechnological applications. Founded in 2016 and based in San Francisco, SyntheX utilizes a synthetic biology-driven approach to efficiently synthesize and identify peptides and macrocycles that disrupt specific intracellular protein-protein interactions. The company’s development portfolio includes stabilized peptide therapeutics, such as STX101 and STX105, aimed at treating certain cancers that evade chemotherapy through homologous recombination. By leveraging genetically engineered circuits and proprietary DNA-encoded libraries, SyntheX targets drug discovery based on synthetic lethality and oncogene addiction, with an emphasis on addressing DNA damage repair and novel cell death mechanisms.

Pendulum Therapeutics Inc., a microbiome company, produces microbiome-targeted medical probiotics. It offers Pendulum Glucose Control, a medical probiotic for the dietary management of type 2 diabetes. The company also develops prebiotics to help feed the probiotic strains. It sells its products online. Pendulum Therapeutics Inc. was formerly known as Whole Biome Inc. and changed its name to Pendulum Therapeutics Inc. in July 2019. The company was incorporated in 2012 and is based in San Francisco, California.

Mindoula Health, Inc. is a mental health care and behavioral health management company based in Silver Spring, Maryland. Established in 2013, it offers a technology-enabled platform that identifies, engages, and supports patients facing complex behavioral, medical, and social challenges throughout the entire continuum of care. The company provides both multiplatform and in-person behavioral health care management services to hospitals, treatment centers, primary care physician practices, and directly to patients and their families. Mindoula operates in multiple states, including Maryland, Virginia, the District of Columbia, Nevada, Louisiana, New Jersey, Michigan, Florida, Texas, Georgia, Pennsylvania, Mississippi, and California.

Privia Health, LLC is a physician practice management and population health technology company based in Arlington, Virginia. Established in 2007, it focuses on enhancing healthcare delivery through its collaboration with physician groups, health plans, and national payers. Privia Health operates a high-performance physician group and an accountable care organization, utilizing a proprietary cloud-based technology platform to improve patient engagement and promote wellness. The company's approach aligns reimbursements with quality outcomes, aiming to keep populations healthy and effectively manage diseases. Privia Health has formed strategic alliances with organizations such as Premier Medical Group and Children’s Health, further strengthening its commitment to delivering high-value care. As a subsidiary of Brighton Health Services Holdings Corp, Privia Health continues to innovate in the healthcare sector.